Drug Laws by State: Marijuana, Psilocybin & Kratom in 2026

Ask "is it legal here?" about any drug in America and the honest answer is a question back: legal according to whom, and legal in which of four quite different senses? A substance can be sold in a licensed store, tolerated with a fine, available only through a supervised clinic, or banned outright — and the same substance can occupy all four positions in four neighboring states. Meanwhile the federal answer often contradicts every one of them.

This guide maps the whole landscape: marijuana, psilocybin, and kratom, the four legal tiers that actually govern them, and why the federal contradiction matters more than most people realize.

The short version

• “Legal,” “decriminalized,” “medical,” and “supervised-access” are four distinct legal states, not synonyms.
• 24 states plus DC allow recreational marijuana; only about a dozen ban it entirely.
• Psilocybin is legal in a handful of states but only through licensed, on-site therapy — never retail.
• Kratom is the inverse case: federally legal, banned in about seven states.
• Marijuana and psilocybin remain federally illegal everywhere, whatever your state has done.

Legal (adult-use)

Adults 21+ may buy from licensed retailers and possess within state limits. A regulated market exists.

Decriminalized

Possession of a small amount remains unlawful but is punished as a civil fine rather than a crime. No legal market exists.

Medical

Access limited to patients with a qualifying condition and a state-issued card, through licensed dispensaries.

Supervised access

Legal only when consumed on-site under a trained facilitator. The model used by every state psilocybin program.

Schedule I

The most restrictive federal drug category — no accepted medical use, illegal nationwide regardless of state law.

The four tiers, and why the distinction matters

Most coverage of drug policy collapses into a binary — legal or not. That binary hides the distinction that actually determines what happens to you.

Consider three people caught with the same quarter-ounce of cannabis. In Colorado, nothing happens; they bought it in a shop. In North Carolina, they get a citation and a fine, and no legal shop exists to have bought it from. In Idaho, they face a criminal misdemeanor. Those are not three points on one spectrum — they are three different legal regimes, and the middle one is the least intuitive, because decriminalization removes the handcuffs without creating a supply.

That gap is the single most misunderstood thing in American drug law. Decriminalization legalizes the conduct of possessing, not the commerce of selling. In a decriminalized state, every gram in circulation still arrived through an illegal transaction. The buyer is protected from a criminal record; the seller is not protected at all.

The tiers also stack. Many recreational states run a parallel medical program, because medical cards carry tax exemptions and higher possession limits. Some prohibition states run a narrow low-THC program and decriminalize personal possession. A single state can occupy three tiers at once for the same plant.

Where is marijuana legal?

Twenty-four states and Washington, D.C. permit adults 21 and older to possess and use cannabis without a medical card:

The pace has been remarkable. Colorado and Washington legalized adult use in 2012 and were alone for two years. The list has more than doubled since, and it has done so largely through ballot initiatives rather than legislatures — voters have repeatedly moved ahead of the politicians they elect, which is why several legalization states have conservative legislatures that would not have passed the measure themselves.

Which states decriminalized without legalizing?

These states treat minor possession as a civil or low-level offense while maintaining prohibition on sales:

This group is worth watching, because decriminalization has historically been a waystation rather than a destination. Most current legalization states passed through it first. The states that have stalled here tend to be the ones without a citizen-initiative process — the reform can pass as a modest criminal-justice tweak, but full legalization requires a legislature to act.

Which states still ban marijuana?

Roughly a dozen states prohibit cannabis outright, with no recreational or comprehensive medical program — though several allow narrow low-THC or CBD products for a short list of conditions. These holdouts cluster in the South and the plains, and they anchor the bottom of the drug-policy ranking.

Psilocybin: legal, but nothing like a dispensary

Psilocybin — the active compound in psilocybin mushrooms — is the clearest example of why "legal" needs qualifying. These states have legalized it:

Oregon opened the first licensed service centers, Colorado followed with dozens of "healing centers," and New Mexico and New Jersey have since enacted programs of their own. But not one of these states has created anything resembling a cannabis dispensary. The model is:

• Access happens at a licensed service center, not a retail store.
• A trained facilitator guides preparation, the session itself, and integration afterward.
• It is consumed on-site. You cannot take it home.
• It is expensive — commonly $1,000–$5,000, because you are buying hours of supervision, not a product.

This is a clinical framework wearing the word "legal." Someone reading a headline about Oregon legalizing psilocybin and expecting a shop will instead find a licensed therapeutic appointment with a waiting list and a price tag.

Separately, a number of cities — Denver, Oakland, San Francisco, Seattle, Ann Arbor — have decriminalized or deprioritized personal psilocybin use. City decriminalization lowers local enforcement priority. It does not make psilocybin legal under state or federal law, and it offers no defense if a state agency decides to prosecute.

Kratom: the case that runs the other way

Kratom inverts every assumption the previous two sections build. It is an herbal substance from the leaves of a Southeast Asian tree, Mitragyna speciosa, sold as capsules, powders, and teas, and used by some for energy, pain, or managing opioid withdrawal.

It is federally legal. The FDA has warned repeatedly about its risks and once moved to schedule it, but public and congressional pushback stalled that effort, and the DEA has never classified it as a controlled substance. With no federal prohibition to work around, regulation fell entirely to the states — and the states diverged immediately.

These states ban it outright:

Everywhere else it is legal, and more than 30 states have adopted some version of a Kratom Consumer Protection Act rather than a ban. A typical KCPA sets a minimum age of 21, requires lab testing and accurate labeling, prohibits adulterated or synthetic products such as concentrated 7-OH, and licenses retailers.

The federal contradiction

Marijuana and psilocybin remain Schedule I controlled substances under federal law: illegal in all fifty states, regardless of what any state has voted for. Kratom is not scheduled at all.

In practice, the federal government has largely declined to enforce against conduct legal under state law. But "largely declined to enforce" is not the same as "lawful," and the difference shows up in places people do not anticipate:

• Banking. Federally chartered banks would be handling proceeds of a federal crime, which is why cannabis businesses have historically run on cash and paid punitive fees for the accounts they can get.
• Interstate commerce. Product cannot legally cross a state line, even between two legalization states. Every legal market is a sealed island with its own cultivation.
• Federal employment and firearms. Federal employees and security-clearance holders remain subject to federal law wherever they live. So does anyone completing a firearms purchase form, which asks about unlawful drug use in federal terms.
• Housing and immigration. Federally subsidized housing and immigration proceedings both apply the federal standard.

This is the practical reason state legalization delivers less than the word implies. A state can stop arresting you. Only Congress can make the activity lawful.

How states rank on drug policy

Our drug-policy score weighs marijuana legality, decriminalization, the severity of possession penalties, and emerging psychedelic policy into one measure of how much latitude a state leaves for personal substance choices:

1. 1. Montana —
   9.5/10 (A+).
2. 2. Arizona —
   9.5/10 (A+).
3. 3. Missouri —
   9.5/10 (A+).
4. 4. Minnesota —
   9.5/10 (A+).
5. 5. Maine —
   9.5/10 (A+).
6. 6. Vermont —
   9.5/10 (A+).
7. 7. Nevada —
   9.5/10 (A+).
8. 8. Alaska —
   9.5/10 (A+).
9. 9. Michigan —
   9.5/10 (A+).
10. 10. Ohio —
    9.5/10 (A+).

See all 50 states ranked on Drug Policy

See all 50 states ranked on drug policy

A color-coded map and the full drug-policy ranking, from most permissive to most restrictive.